Development of a new chemo-enzymatic catalytic route for synthesis of (S)− 2-chlorophenylglycine

Feng Cheng,Wei-Bang Xie,Xiao-Fan Gao,Rong-Liang Chu,Shen-Yuan Xu,Ya-Jun Wang,Yu-Guo Zheng

DOI: https://doi.org/10.1016/j.jbiotec.2022.08.013

IF: 3.595

2022-11-10

Journal of Biotechnology

Abstract:(S)-2-chlorophenylglycine ((S)-CPG) is a key chiral intermediate for the synthesis of clopidogrel. Herein, a novel, efficient and environmentally friendly chemo-enzymatic route for the preparation of optically pure (S)-CPG was developed. A straightforward chemical synthesis of the corresponding prochiral keto acid substrate (2-chlorophenyl)glyoxylic acid (CPGA) was developed with 91.7% yield, which was enantioselectively aminated by leucine dehydrogenase (LeuDH) to (S)-CPG. Moreover, protein engineering of LeuDH was performed via directed evolution and semi-rational design. A beneficial variant EsLeuDH-F362L with enlarged substrate-binding pocket and increased hydrogen bond between K77 and substrate CPGA was constructed, which exhibited 2.1-fold enhanced specific activity but decreased thermal stability. Coupled with a glucose dehydrogenase from Bacillus megaterium (BmGDH) for NADH regeneration, EsLeuDH-F362L completely converted up to 0.5 M CPGA to (S)-CPG in 8 h at 40 °C.

biotechnology & applied microbiology

What problem does this paper attempt to address?

The problem this paper attempts to address is how to develop a novel, efficient, and environmentally friendly chemo-enzymatic route to synthesize optically pure (S)-2-chlorophenylglycine ((S)-CPG). (S)-2-chlorophenylglycine is a key chiral intermediate in the synthesis of the antiplatelet drug clopidogrel. Currently, various synthetic strategies are available for the preparation of enantiomerically pure clopidogrel, but these methods often suffer from harsh reaction conditions and complex post-treatment processes. Therefore, this paper aims to develop a new synthetic route by combining the advantages of chemical synthesis and biocatalysis to improve the yield and optical purity of (S)-2-chlorophenylglycine. Specifically, the main contributions of the paper include: 1. **Chemical synthesis of prochiral keto acid**: The prochiral keto acid (2-chlorophenyl)glyoxylic acid (CPGA) was synthesized by chemical methods with a yield of 91.7%. 2. **Enzyme-catalyzed asymmetric amination**: Leucine dehydrogenase (LeuDH) was used for the enantioselective amination of CPGA to generate (S)-CPG. 3. **Protein engineering optimization**: LeuDH was modified through directed evolution and semi-rational design, resulting in a beneficial mutant EsLeuDH-F362L, which has a larger substrate-binding pocket and enhanced hydrogen bonding, thereby improving specific activity. 4. **Dual-enzyme biosynthesis system**: Combined with glucose dehydrogenase (BmGDH) for NADH regeneration, the system achieved the complete conversion of CPGA to (S)-CPG under mild conditions with high efficiency. In summary, this study aims to develop an efficient and environmentally friendly method for synthesizing optically pure (S)-2-chlorophenylglycine through a chemo-enzymatic route to meet the production needs of clopidogrel.

Development of a new chemo-enzymatic catalytic route for synthesis of (S)− 2-chlorophenylglycine

Efficient Production of S-(+)-2-chlorophenylglycine by Immobilized Penicillin G Acylase in a Recirculating Packed Bed Reactor

Bioproduction of ( 2R,3R )-3-phenylglycidiol: A Key Chiral Synthon for Drugs Bearing 3-Phenylpropane Using a Newly-Isolated Strain of Aspergillus Fumigatus ZJUTZQ160

Improved Enantioselectivity of E. Coli BioH in Kinetic Resolution of Methyl (S)-3-cyclohexene-1-carboxylate by Combinatorial Modulation of Steric and Aromatic Interactions

An Effective Chemo-Enzymatic method with An Evolved L-Threonine Aldolase for Preparing L-threo-4-Methylsulfonylphenylserine Ethyl Ester of High Optical Purity

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Computer-Aided Flexible Loops Engineering of Glutamate Dehydrogenase for Asymmetric Synthesis of Chiral Pesticides l-phosphinothricin

Biocatalytic Synthesis of a Key Chiral Delamanid Precursor using an Engineered P450 Monooxygenase

Development of a Novel Chemoenzymatic Process for ( S )-1-(Pyridin-4-yl)-1,3-propanediol

Ethanol-assisted mechanochemical asymmetric cross-dehydrogenative coupling reaction with recoverable chiral amine/NaCl for accessing chiral α-alkyl α-glycine derivatives

Directed evolution of a carbonyl reductase LsCR for the enantioselective synthesis of (1S)-2-chloro-1-(3,4-difluorophenyl) ethanol

Protein engineering of carbonyl reductase for asymmetric synthesis of ticagrelor precursor (1S)-2-chloro-1-(3,4-difluorophenyl)ethanol

Preparation of (S)-epichlorohydrin using a novel halohydrin dehalogenase by selective conformation adjustment

One-step eantioselective bioresolution for (S)-2-chlorophenylglycine methyl ester catalyzed by the immobilized Protease 6SD on multi-walled carbon nanotubes in a triphasic system

Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli

Rational design of short-chain dehydrogenase/reductase for enantio-complementary synthesis of chiral 1,2-diols by successive hydroxymethylation and reduction of aldehydes

Rational design of the carbonyl reductase EbSDR8 for efficient biosynthesis of enantiopure (R)-3-chloro-1-phenyl-1-propanol

Facile Asymmetric Syntheses of Non-Natural Amino Acid (S)-Cyclopropylglycine by the Developed NADH-Driven Biocatalytic System

Highly efficient synthesis of the chiral ACE inhibitor intermediate (R)-2-hydroxy-4-phenylbutyrate ethyl ester via engineered bi-enzyme coupled systems

Pd(II)-Catalyzed Enantioselective C—H Olefination of 2-(Arylsulfinyl)pyridines Through Kinetic Resolution

Engineering of Cyclohexanone Monooxygenase for the Enantioselective Synthesis of (S)-Omeprazole